Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group

References

• Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999; 17: 2334–2340
   PubMed Web of Science ®Google Scholar
• Lauridsen MC, Garne JP, Sorensen FB, Melsen F, Lernevall A, Christiansen P, et al. Sentinel lymph node biopsy in breast cancer--experience with the combined use of dye and radioactive tracer at Aarhus University Hospital. Acta Oncol 2004; 43: 20–26
   PubMed Web of Science ®Google Scholar
• Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999; 84: 138–142
   PubMed Web of Science ®Google Scholar
• Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer. N Engl J Med 2003; 349: 546–553
   PubMed Web of Science ®Google Scholar
• Swenson KK, Mahipal A, Nissen MJ, Tuttle TM, Heaton K, Lally RM, et al. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer 2005; 104: 1834–1839
   PubMed Web of Science ®Google Scholar
• Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. J Surg Oncol 2006; 93: 129–132
   PubMedGoogle Scholar
• Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394–399
   PubMed Web of Science ®Google Scholar
• Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006; 106: 4–16
   PubMed Web of Science ®Google Scholar
• Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20: 3628–3636
   PubMed Web of Science ®Google Scholar
• Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheijmans LJ, van Beek MW, Roumen RM. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol 2005; 31: 500–505
   PubMed Web of Science ®Google Scholar
• Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini et al Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001; 92:1378–1384.
   PubMed Web of Science ®Google Scholar
• Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005; 241: 319–325
   PubMed Web of Science ®Google Scholar
• Galimberti V. International Breast Cancer Study Group Trial of Sentinel Node Biopsy. J Clin Oncol 2006; 24: 210–211
   PubMedGoogle Scholar
• Koscielny S, Tubiana M, Le MG, Valleron AJ, Mouriesse H, Contesso G, et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 1984; 49: 709–715
   PubMed Web of Science ®Google Scholar
• Jensen AR. A comparative population based study on breast cancer patients in Denmark and Sweden – Aspects of early diagnosis, axillary surgery and registration. 2002. Faculty of Health Sciences, University of Aarhus.
   Google Scholar
• Jensen AR, Garne JP, Storm HH, Engholm G, Moller T, Overgaard J. Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?. Acta Oncol 2004; 43: 719–726
   PubMed Web of Science ®Google Scholar
• van der Heiden-van der Loo, Bezemer PD, Hennipman A, Siesling S, van Diest PJ, Bongers V, et al Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 2006; 32:710–714.
   PubMedGoogle Scholar
• Vanderveen KA, Schneider PD, Khatri VP, Goodnight JE, Bold RJ. Upstaging and Improved Survival of Early Breast Cancer Patients after Implementation of Sentinel Node Biopsy for Axillary Staging. Ann Surg Oncol 2006.
   PubMedGoogle Scholar
• Jensen AR, Overgaard J, Storm HH. Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 2002; 11: 359–364
   PubMed Web of Science ®Google Scholar
• Jensen AR, Storm HH, Moller S, Overgaard J. Validity and representativity in the Danish Breast Cancer Cooperative Group--a study on protocol allocation and data validity from one county to a multi-centre database. Acta Oncol 2003; 42: 179–185
   PubMed Web of Science ®Google Scholar
• Rostgaard K, Holst H, Mouridsen HT, Lynge E. Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control 2000; 11: 669–674
   PubMed Web of Science ®Google Scholar
• Key Indicators. Statistics Denmark www.dst.dk. 2006.
   Google Scholar
• DBCG. Guidelines from the Danish Breast Cancer Cooperative Group. www.dbcg.dk. 2006.
   Google Scholar
• Flemming ID, Cooper JS, Henson DE, Hutter RV, Kennedy BJ, Murphy GP, et al “AJJC Cancer Staging Manual.” Lippincott - Raven, 1997.
   Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403–410
   PubMed Web of Science ®Google Scholar
• Galimberti V, Veronesi P, Arnone P, De CC, Renne G, Intrntra M, et al. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 2002; 9: 924–928
   PubMed Web of Science ®Google Scholar
• Tjan-Heijnen VC, Buit P, de Widt-Evert LM, Ruers TJ, Beex LV. Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 2001; 70: 81–88
   PubMedGoogle Scholar
• Feinstein AR, Sosin DA, Wells CK. The Will Rogers Phenomenon: Improved technologic diagnosis and stage migration as a source of nontherapeutic improvement in cancer prognosis. Transactions of the Association of American Physicians 1984; 97: 19–24
   PubMedGoogle Scholar
• Weaver DL. Pathological evaluation of sentinel lymph nodes in breast cancer: a practical academic perspective from America. Histopathology 2005; 46: 702–706
   PubMedGoogle Scholar
• van Rijk MC, Deurloo EE, Nieweg OE, Gilhuijs KG, Petersen JL, Rutgers EJ, et al. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 2006; 13: 31–35
   PubMed Web of Science ®Google Scholar
• Cancer incidence in Denmark 2001. National Board of Health 2006; Copenhagen.
   Google Scholar
• Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 2006; 119: 2417–2422
   PubMedGoogle Scholar
• Saha S, Farrar WB, Young DC, Ferrara JJ, Burak WE. Variation in axillary node dissection influences the degree of nodal involvement in breast cancer patients. J Surg Oncol 2000; 73: 134–137
   PubMedGoogle Scholar
• Grabau DA, Jensen MB, Blichert-Toft M, Andersen JA, Dyreborg U, Carstensen B, et al. The importance of surgery and accurate axillary staging for survival in breast cancer. European Journal of Surgical Oncology 1998; 24: 499–507
   PubMed Web of Science ®Google Scholar